Literature DB >> 2337792

Sustained behavioral recovery from unilateral nigrostriatal damage produced by the controlled release of dopamine from a silicone polymer pellet placed into the denervated striatum.

J B Becker1, T E Robinson, P Barton, A Sintov, R Siden, R J Levy.   

Abstract

This study was conducted to determine if the behavioral asymmetry associated with unilateral nigrostriatal dopamine (DA) depletion could be alleviated by placing a small DA-releasing silicone polymer matrix pellet into the denervated striatum of rats. Animals that received DA-releasing pellets showed a 50% reduction in apomorphine-induced rotational behavior, and this effect persisted for the 2-month duration of the experiment. The results suggest that the controlled release of DA from an intrastriatal polymer matrix can produce a long-lasting reduction in some of the symptoms associated with DA depletion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337792     DOI: 10.1016/0006-8993(90)91117-y

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

Review 1.  Behavioural consequences of neural transplantation.

Authors:  S B Dunnett
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

Review 2.  Distribution of drugs following controlled delivery to the brain interstitium.

Authors:  M Mak; L Fung; J F Strasser; W M Saltzman
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

3.  Seizure suppression in kindling epilepsy by intracerebral implants of GABA- but not by noradrenaline-releasing polymer matrices.

Authors:  M Kokaia; P Aebischer; E Elmér; J Bengzon; P Kalén; Z Kokaia; O Lindvall
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

4.  Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats.

Authors:  A McRae; E A Ling; S Hjorth; A Dahlström; D Mason; T Tice
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.